Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease

Respiratory Medicine

Volumn 95, Issue 11, 2001, Pages 891-897

  Dahlen I ^a,b   Janson, C ^a,b   Bjornsson E ^a,b   Stalenheim G ^a,b   Peterson, C G B ^c   Venge, P ^b  

^a Department of Medical Sciences   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c PFIZER INC   (United States)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Eosinophils; Exacerbation; Neutrophils

Indexed keywords

BUDESONIDE; CELL MARKER; EOSINOPHIL CATIONIC PROTEIN; LIPOCALIN; MYELOPEROXIDASE; PEROXIDASE; PLACEBO; PREDNISOLONE; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; BLOOD SAMPLING; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MARKER; EMERGENCY TREATMENT; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; SPIROMETRY; TREATMENT OUTCOME;

EID: 0035176944     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2001.1179     Document Type: Article

References (23)

1. Bronchial biopsies and airway inflammation
2. Cellular infiltrates in asthma and chronic obstructive pulmonary disease
3. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease
4. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage
5. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: Relation to disease status and therapy
6. 20, and exacerbations
7. Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course
8. Serum eosinophil cationic protein levels and bronchodilator responses at acute asthma exacerbation
9. Inflammatory markers in acute exacerbations of obstructive pulmonary disease. Predictive value in relation to smoking history
10. Standardized lung function testing
11. Human eosinophil peroxidase: Purification and characterization
12. The development of an assay for human neutrophil lipocalin (HNL)-to be used as a specific marker of neutrophil activity in vivo and vitro
13. Relationship of skin test reactivity and eosinophilia to level of pulmonary function in a community-based population study
14. BTS guidelines for the management of chronic obstructive pulmonary disease
15. Relevance of serum ECP measurements for monitoring acute asthma in children
16. Serum eosinophil cationic protein measurements in the management of perennial and periodic asthma: A prospective study
17. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking
18. Sputum in severe exacerbations of asthma: Kinetics of inflammatory indices after prednisone treatment
19. + T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease
20. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage
21. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids
22. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation
23. Bronchial neutrophilia in patients with noninfectious status asthmaticus